Exercise of the over-allotment option in Humana
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG OR SINGAPORE The Managers (as defined below) have notified Humana AB (“Humana” or the “Company”) and Humana’s principal owner, funds advised or managed by Argan Capital Management L.P. (“Argan Capital”) that the over-allotment option has been exercised in full in respect of 1,683,029 existing shares in Humana.· In connection with the initial public offering of Humana, Argan Capital granted the Managers an over-